Literature DB >> 29394968

Evaluation of Diagnostic Scores for Acute Appendicitis.

Wu Xingye1, Li Yuqiang1, Wang Rong1, Zhang Hongyu1.   

Abstract

OBJECTIVE: To assess the sensitivity of the Alvarado score (AS), modified Alvarado score (MAS), Fenyo-Lindberg score (FS), Lintula score (LS), Eskelinen score (ES), Teicher score (TS), and Christian score (CS) [seven scorings] in patients with acute appendicitis (AA). STUDY
DESIGN: Analytical study. PLACE AND DURATION OF STUDY: The First Affiliated Hospital of Chongqing Medical University, China, from January 2012 to June 2015.
METHODOLOGY: Patients with diagnosis of AA were evaluated retrospectively to compare the scoring systems. The diagnostic sensitivity (the correct number of diagnoses divided by the total number) was compared. Data were analyzed using SPSS software.
RESULTS: One hundred and seventy-nine patients were studied. The sensitivity of AS was 92.7%; It outperformed each of the other scores. The sensitivity of FS, LS, and TS in women was lower than that in men (p=0.016, p<0.001, and p<0.001, respectively). The sensitivity of the FS, ES, TS, and CS in patients with a duration of illness greater than 48 hours was lower than that in patients with a duration of illness less than 48 hours (p<0.001 for all).
CONCLUSION: AS is the most useful and sensitive diagnostic tool for AA. FS, LS, and TS had a lower diagnostic sensitivity in women; and FS, ES, TS, and CS had a low sensitivity in patients with a duration of illness greater than 48 hours.

Entities:  

Mesh:

Year:  2018        PMID: 29394968     DOI: 10.29271/jcpsp.2018.02.110

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  1 in total

1.  Serum bilirubin concentration as a marker of severity of acute appendicitis.

Authors:  Maciej Jastrzębski; Maciej Krasnodębski; Michalina Szczęśniak; Michał Wierzchowski; Julia Pikul; Dariusz Jabłoński; Michał Grąt; Tadeusz Wróblewski; Krzysztof Zieniewicz
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-08-22       Impact factor: 1.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.